Serial 86823176
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 10 Sept 2025)
What this means for you
Registered since 02 Jan 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86823176
- Registration number
- 5370601
- Mark type
- Design / logo
- Filed
- 17 Nov 2015
- Published for opposition
- 15 Mar 2016
- Registered
- 02 Jan 2018
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prophylaxis of infectious diseases, cancer and immune system diseases and disorders, auto immune system diseases, and blood disorders
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields
Owner
- APTEVO THERAPEUTICS INC., Seattle, WA, US
- APTEVO THERAPEUTICS INC., SEATTLE, WA, US
- APTEVO RESEARCH AND DEVELOPMENT LLC, SEATTLE, WA, US
- APTEVO RESEARCH AND DEVELOPMENT LLC, SEATTLE, WA, US
- Emergent Product Development Seattle, LLC, Seattle, WA, US
- Emergent Product Development Seattle, LLC, Seattle, WA, US
Prosecution history
- 10 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 10 Sept 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 16 May 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 16 Nov 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 16 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Jun 2024 — TEAS SECTION 8 & 15 RECEIVED
- 02 Jan 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Jan 2018 — REGISTERED-PRINCIPAL REGISTER
- 25 Nov 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Nov 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Nov 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Nov 2017 — USE AMENDMENT FILED
- 22 Nov 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Nov 2017 — TEAS STATEMENT OF USE RECEIVED
- 08 Nov 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED